Semaglutide (Wegovy): Designed for weight loss, clinical trials show an average reduction of 1520% of body weight over 612 months with proper diet and exercise
However, this does not have to be our destiny
The raw data was processed by the ArrayExpress R package (version 1.62.0, Subsequently, the sva R package (version 3.50.0, was employed to eliminate batch effects and to integrate the expression profile data from datasets GSE106724, GSE137684, and GSE95728
Prescribed Semaglutide can lead to significant weight loss , improved blood sugar control, and reduced cardiovascular risk, providing freedom from obesity-related ailments
Final Thought GLP-1s can be a powerful accelerator for weight lossbut without the right nutritional and lifestyle foundation, they may leave people metabolically worse off in the long run
112 MitraR.RichhariyaS.HasanG